Platysma Botox | Newest FDA Approved Location for Botox

In a new advancement for aesthetic medicine, the FDA has approved Botox for the vertical bands connecting the jaw and neck. This area is more commonly known as the platysma bands. Announced in October 2024, this is Botox’s first approved use beyond the face, expanding its application to the neck area. 

The platysma is a thin, superficial muscle that extends from the chest up to the lower face. Over time, repetitive muscle activity and aging can cause this muscle to become more prominent. This can lead to visible vertical bands on the neck and a less defined jawline. 

This breakthrough allows providers to offer a non-surgical, injectable option for patients concerned about neck aging and looking for a treatment to fight the signs. “With the neck being in the top 3 areas that age you most, this is a great tool in our toolbox to continue to help with a natural, graceful aging approach,” adds Anna Lunning, CNP.

The treatment involves precise injections to the vertical bands on the neck. This temporarily relaxes the underlying muscles to reduce their appearance. Depending on the patient, the amount of units ranges from 8-16, which equates to around 4 units per band. Patients typically see improvements within two weeks, with results lasting approximately three months. 

This development provides patients with more comprehensive options for addressing signs of aging. It also extends the benefits of Botox treatments beyond the face to include the neck and jawline.

If you’re ready to explore this exciting new treatment and achieve a smoother, more youthful neckline, schedule your appointment today! We’re here to help you age gracefully, from face to neck.